Enforcement Response Register

GlaxoSmithKline Consumer Health Care New Zealand Limited

Return to Summary

Parties GlaxoSmithKline Consumer Health Care New Zealand Limited
Sections Fair Trading Act 10, 13(e)
Description GlaxoSmithKline Consumer Health Care New Zealand Limited has been warned for likely breaching section 10 and 13(e) of the Fair Trading Act for misrepresentation as to the nature or characteristics of goods or their suitability for a purpose relating to Voltaren and Panadol products.
Resolution Warning letter
Year 2017
Media release Commission issues warnings to GSK and AFT over Voltaren, Panadol and Maxiclear
Downloads